Back to trial details

Intake questionnaire

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

Applying to Center for Neurosciences · Tucson, Arizona

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you between 18 and 65 years old?
2. Have you been diagnosed with Secondary Progressive Multiple Sclerosis (SPMS)?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Tucson for study visits?